Business Wire › December 09, 2005
Linked as:Extract
Callisto Corporate Video Presentation Focuses on Company's Anti-Cancer Drug Candidates as Second Clinical Trial Starts; Video Presentation Spotlights Company's Drug Candidates to Treat Relapsed Leukemia and Multiple Myeloma Cancers.
NEW YORK -- Callisto Pharmaceuticals, Inc. (AMEX:KAL) (FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, has released a corporate video presentation outlining the Company's current lead anti-cancer drug candidates, Atiprimod and L-Annamycin. Following the rece...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
Senators Filibuster Overnight Tactic Holds Up Vote On Mohela. | With Sashiko Quilting, the Stitching Stands Out | Greenville Legion Post to Honor Wwii Veterans | proquest launches digital obituary collection | Decisión de Juzgado Cuarto De Primera Instancia De Juicio Del Trabajo de Caracas de May 21 2007 | Decisión de Juzgado Ejecutor de Medidas del Municipio Puerto Cabello y Juan José Morade de Carabobo, de November 02, ... | Sentencia nº 2692 de Consiglio di Stato May 21 2008 | Decisión de Juzgado Vigésimo Quinto De Primera Instancia De Sustanciación, Mediación Y Ejecución Del Trabajo de Caracas...
